Background: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports of ...
IMMUNIZATIONS combining diphtheria and tetanus toxoids with pertussis vaccine, using alum or aluminum hydroxide as an adjuvant, have been reported in studies by di Sant' Agnese, 1 Volk, 2 Fleming 3 ...
US consumer and retailer demand to remove aluminum-based leavening agents from baked goods due to health concerns are rising even though FDA considers them GRAS, but efforts to replicate the speed and ...
Modern vaccines elicit protective immunity not only by presenting antigens to the adaptive immune systems, but also by stimulating the innate immune response to the antigens by immunostimulatory ...
Oral phosphate binding agents have been used for the treatment of hyperphosphatemia in dialysis patients for decades. Their safety record was marred in the early 1980's by reports of aluminium-related ...